Tara Comonte

Tara is CEO of TMRW Life Sciences, Inc., the creator of the world’s first and only automated platform for the management of frozen eggs and embryos in the fast-growing in vitro fertilization (IVF) sector. Tara is a passionate advocate for driving innovation and accelerated use of technology to benefit women’s health and the broader fertility field. Previously President and CFO at Shake Shack (NYSE: SHAK), the high growth, global, publicly traded restaurant chain, Tara was instrumental in the company’s accelerated implementation of people- and customer-first digital and technology solutions, resulting in significant value creation, and oversaw a host of additional enterprise-wide technology initiatives. She was the executive sponsor and lead architect in the expansion and formalization of Shake Shack’s diversity and inclusion strategies, an area in which she is deeply passionate. She also led the company's successful April 2020 $150 million equity offering and their subsequent March 2021 $250 million convertible bond issuance. Prior to Shake Shack, Tara held C-level positions at large public and private equity owned media companies, including Getty Images and McCann Worldgroup, part of Fortune 500 public company Interpublic Group (NYSE: IPG). Earlier in her career, Tara was a founding executive and Global CFO & COO of Mediabrands, IPG’s award-winning media group, managing more than $30 billion in billings globally. Tara has been named a World Economic Forum Young Global Leader, was the first CFO inducted into the American Advertising Federation Hall of Achievement, received the Industry Innovator & Quantum Leap Award from Advertising Women of New York, and is a Crain’s New York Business '40 under 40'. Tara is also a member of the Board of Directors at Strava, the leading subscription platform for connected fitness.

Paying it forward, the power of perspective from travel, building high-performing teams

The next 10 years will see the complete transformation of fertility healthcare. Billions of dollars have been invested in the field over the last few years yet we’ve seen little overall change to date. New technologies now provide the path for modernisation and democratisation of fertility care. The result will be the transformation of a niche, artisan, inaccessible part of healthcare today into one that all who need it can benefit from.